ETFs that hold Protagonist Therapeutics Inc
25 US listed ETFs hold Protagonist Therapeutics Inc. PBE holds the most, at 2.69% of the fund.
Every fund that holds it
| Fund | Name | Share of the fund | Holdings filed |
|---|---|---|---|
| PBE | Invesco Biotechnology & Genome ETF | 2.69% | Sep 19, 2026 |
| XBI | State Street SPDR S&P Biotech ETF | 1.30% | Sep 17, 2026 |
| IJT | iShares S&P Small-Cap 600 Growth ETF | 1.04% | Sep 17, 2026 |
| WDNA | WisdomTree BioRevolution Fund | 1.03% | Jun 30, 2026 |
| BMED | iShares Health Innovation Active ETF | 0.91% | Sep 17, 2026 |
| BBC | Virtus Biotech Clinical Trials ETF | 0.77% | Apr 30, 2026 |
| IBB | iShares Biotechnology ETF | 0.63% | Sep 17, 2026 |
| IBBQ | Invesco Nasdaq Biotechnology ETF | 0.62% | Sep 19, 2026 |
| IWO | iShares Russell 2000 Growth ETF | 0.58% | Sep 17, 2026 |
| TNXT | T. Rowe Price Innovation Leaders ETF | 0.56% | Jun 30, 2026 |
| IJR | iShares Core S&P Small-Cap ETF | 0.50% | Sep 17, 2026 |
| FTKI | First Trust Small Cap BuyWrite Income ETF | 0.37% | Sep 18, 2026 |
| IWM | iShares Russell 2000 ETF | 0.29% | Sep 17, 2026 |
| VTWO | Vanguard Russell 2000 ETF | 0.28% | Aug 31, 2026 |
| VBK | Vanguard Morningstar Small-Cap Growth ETF | 0.28% | Aug 31, 2026 |
| ITWO | ProShares Russell 2000 High Income ETF | 0.17% | May 31, 2026 |
| VB | Vanguard Morningstar Small-Cap ETF | 0.12% | Aug 31, 2026 |
| VXF | Vanguard Extended Market ETF | 0.11% | Aug 31, 2026 |
| VHT | Vanguard Health Care ETF | 0.10% | Aug 31, 2026 |
| ONEQ | Fidelity Nasdaq Composite Index ETF | 0.01% | May 31, 2026 |
| VTI | Vanguard Morningstar Total Stock Market ETF | 0.01% | Aug 31, 2026 |
| ITOT | iShares Core S&P Total U.S. Stock Market ETF | 0.01% | Sep 17, 2026 |
| SCHB | Schwab U.S. Broad Market ETF | 0.01% | Jun 30, 2026 |
| VT | Vanguard Total World Stock Index ETF | 0.01% | Aug 31, 2026 |
| DFUS | Dimensional U.S. Equity Market ETF | 0.01% | Apr 30, 2026 |
What this counts
Protagonist Therapeutics Inc (ticker PTGX) is matched across every holdings book ETFIQ publishes, by its ticker together with its name. A share of the fund is the weight the issuer itself published, as of the date in the last column. Option contracts, swaps, futures, cash and money market holdings are not counted as holding a company: a fund holding a call option on a share does not hold the share. Funds whose published book is gross exposure rather than a portfolio are left out entirely, because a weight in such a book is not a share of anything.
Holdings change. Each row carries the date the fund last filed, and a fund that files quarterly can have traded since.
Cite this page. ETFIQ, ETFs holding Protagonist Therapeutics Inc, data as of Sep 21, 2026. https://etfiq.com/holdings/ptgx/ Free to use with attribution; the underlying files are at Open data.